Gains in childhood cancer survival slow

02/19/2013 | Bloomberg Businessweek

Although the five-year survival rate of children with cancer increased from 30% in the 1960s to 80% in 2000s, improvement has leveled off, physicians wrote in Lancet Oncology. The report's authors say the approach to research and regulation must be modernized to address the issue. Just 15 childhood cancer drugs have been allowed for use in children since 1998.

View Full Article in:

Bloomberg Businessweek

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA